NCT03225547 2025-12-23
Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
University of Chicago
Phase 2 Terminated
University of Chicago
University of California, San Diego
New Mexico Cancer Research Alliance
Poitiers University Hospital